Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors

This study aimed to access the predictive value of inflammatory indices and clinical factors in toxicity and survival in patients with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma receiving first-line tyrosine kinase inhibitor (TKI)-treatment. A total of 259 patients with stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Bee-Song, Peng, Tai-Chu, Wu, Yi-Feng, Hsieh, Tsung-Cheng, Huang, Chun-Hou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955131/
https://www.ncbi.nlm.nih.gov/pubmed/35330404
http://dx.doi.org/10.3390/jpm12030404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955131/
https://www.ncbi.nlm.nih.gov/pubmed/35330404
http://dx.doi.org/10.3390/jpm12030404

Ejemplares similares